TransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Core Viewpoint - TransMedics Group, Inc. is set to release its financial results for Q4 and the full year 2024 on February 27, 2025, after market close, followed by a conference call with management [1] Company Overview - TransMedics is a leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation, headquartered in Andover, Massachusetts [3] - The company was founded to address the need for more and better organs for transplantation, developing technologies to preserve organ quality and assess organ viability prior to transplant [3]